Lamotrigine tablet

DRUG4 trials

Sponsors

GlaxoSmithKline, University of Karachi, Gitte Moos Knudsen, Dhaka Medical College

Conditions

BioequivalenceEpilepsyFocal Epilepsy

Phase 1

Bioequivalence and Food Effect of 250mg of Lamotrigine XR

CompletedNCT00605371

GlaxoSmithKlineEpilepsy

Start: 2008-01-15End: 2008-03-06Updated: 2017-09-11

Bioequivalence of Lamnet (Lamotrigine)100mg Tablet With the Reference Product Lamictal 100mg (Lamotrigine) Tablet Under Fasting Conditions

CompletedNCT04938856

University of KarachiBioequivalence

Start: 2020-09-04End: 2020-10-25Updated: 2022-09-08

Phase 4

The Efficacy and Safety of Lamotrigine Versus Carbamazepine in Focal Epilepsy

Dhaka Medical CollegeFocal Epilepsy

Start: 2022-11-01End: 2023-10-31Target: 70Updated: 2023-10-10

Unknown Phase

Precision Medicine in the Treatment of Epilepsy

RecruitingNCT05450822

Gitte Moos KnudsenEpilepsy

Start: 2022-02-18End: 2031-12-31Target: 550Updated: 2024-04-11

Related Papers

Assessment of cerebral drug occupancy in humans using a single PET-scan: A [<sup>11</sup>C]UCB-J PET study.

2024-05-17

The BrainDrugs-epilepsy study: A prospective open-label cohort precision medicine study in epilepsy

Neuroscience Applied2023-01-012 citations